Literature DB >> 23180650

Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library.

Mingkui Zhou1, Torsten Meyer, Stefanie Koch, Joachim Koch, Hagen von Briesen, José M Benito, Vincent Soriano, Annette Haberl, Markus Bickel, Stefan Dübel, Michael Hust, Ursula Dietrich.   

Abstract

HIV controllers are a valuable source for the identification of HIV-neutralizing antibodies, as chronic infection over decades allows extensive affinity maturation of antibodies for improved Ag recognition. We analyzed a small cohort of elite controllers (ECs) for HIV-neutralizing antibodies using a panel of standardized HIV-1 pseudovirions on TZM-bl cells. An HIV-1 Env-tailored phage display library was generated to select epitopes targeted by neutralizing antibodies in the EC26 plasma sample showing the broadest neutralizing activity. Selected Env fragments were mostly allocated to the membrane proximal external region of gp41. After preabsorbing the EC26 plasma with the selected phage EC26-2A4, we achieved 50% depletion of its neutralizing activity. Furthermore, antibodies affinity-purified with the EC26-2A4 epitope from EC26 plasma showed neutralizing activity, proving that the selected phage indeed contains an epitope targeted by neutralizing plasma antibodies. Epitope fine mapping of the purified plasma antibodies on peptide arrays identified a new epitope overlapping, but clearly distinct, from the prominent 2F5 epitope. Of note, the purified antibodies did not show autoreactivity with cardiolipin, whereas low reactivity with phosphatidylserine comparable to mAb 2F5 was observed. Thus, this new epitope represents a promising candidate for further analysis in view of HIV vaccine development.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180650     DOI: 10.1002/eji.201242974

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surface.

Authors:  Gertrudis Rojas; Yaima Tundidor; Yanelys Cabrera Infante
Journal:  MAbs       Date:  2014       Impact factor: 5.857

Review 2.  Peptides for Vaccine Development.

Authors:  Ian W Hamley
Journal:  ACS Appl Bio Mater       Date:  2022-02-23

Review 3.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

4.  Multimeric scaffolds displaying the HIV-1 envelope MPER induce MPER-specific antibodies and cross-neutralizing antibodies when co-immunized with gp160 DNA.

Authors:  Shelly J Krebs; Sean P McBurney; Dina N Kovarik; Chelsea D Waddell; J Pablo Jaworski; William F Sutton; Michelle M Gomes; Maria Trovato; Garret Waagmeester; Susan J Barnett; Piergiuseppe DeBerardinis; Nancy L Haigwood
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 5.  Phage display-derived human antibodies in clinical development and therapy.

Authors:  André Frenzel; Thomas Schirrmann; Michael Hust
Journal:  MAbs       Date:  2016-07-14       Impact factor: 5.857

Review 6.  The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.

Authors:  Oliver Ringel; Vincent Vieillard; Patrice Debré; Jutta Eichler; Hildegard Büning; Ursula Dietrich
Journal:  Viruses       Date:  2018-04-15       Impact factor: 5.048

7.  Antibody response against selected epitopes in the HIV-1 envelope gp41 ectodomain contributes to reduce viral burden in HIV-1 infected patients.

Authors:  Rute Marcelino; Filipa Gramacho; Francisco Martin; Pedro Brogueira; Nuno Janeiro; Claudia Afonso; Robert Badura; Emília Valadas; Kamal Mansinho; Luís Caldeira; Nuno Taveira; José M Marcelino
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

Review 8.  Oligopeptide m13 phage display in pathogen research.

Authors:  Jonas Kügler; Jonas Zantow; Torsten Meyer; Michael Hust
Journal:  Viruses       Date:  2013-10-16       Impact factor: 5.048

9.  Functional characterization of two scFv-Fc antibodies from an HIV controller selected on soluble HIV-1 Env complexes: a neutralizing V3- and a trimer-specific gp41 antibody.

Authors:  Maria Trott; Svenja Weiβ; Sascha Antoni; Joachim Koch; Hagen von Briesen; Michael Hust; Ursula Dietrich
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

10.  Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.

Authors:  Oliver Ringel; Karsten Müller; Joachim Koch; Boris Brill; Timo Wolf; Christoph Stephan; Vincent Vieillard; Patrice Debré; Ursula Dietrich
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-25       Impact factor: 2.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.